Starting
Initialising…
0%
ATM
Final classification
VUS
ATM c.8418+5_8418+8del · p.?
ATM

The ATM c.8418+5_8418+8del (NP_000042.3:p.?) variant has not been reported in ClinVar.

Gene
ATM
Transcript
NM_000051.4
HGVS · transcript:coding
NM_000051.4:c.8418+5_8418+8del
Consequence
N/A
GRCh38
chr11:108343371 GGTGA>G
GRCh37
chr11:108214098 GGTGA>G
Basis Richards et.al., 2015 - Combining rules v1.5.0 criteria-combination framework was evaluated deterministically with applied criteria: PP3 supporting; no rule matched the adjudicated criteria.
Richards et.al., 2015 - Combining rules v1.5.0 criteria-combination framework was evaluated deterministically with applied criteria: PP3 supporting; no rule matched the adjudicated criteria.
Classification rationale
PP3 VUS
ATM c.8418+5_8418+8del

The ATM c.8418+5_8418+8del (NP_000042.3:p.?) variant has not been reported in ClinVar.1 This variant is present in gnomAD v4.1 at AF 0.00465% (75/1,613,598 alleles; grpmax FAF 0.005111%) and in gnomAD v2.1 at AF 0.00071% (2/282,394 alleles), which is above the ATM PM2_Supporting threshold of 0.001% and below the BS1 threshold of 0.05%.2 SpliceAI predicts an adverse splicing effect with a maximum delta score of 0.89, which exceeds the ATM PP3 threshold of 0.2 for intronic variants outside the donor ±1,2 positions and supports PP3.3

PP3 VUS
Gene diagram · NM_000051.4 · variants mapped to exon structure
ATM NM_000051.4
Fetching transcript structure from UCSC…
Applied criteria · 1 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 4.648e-05; MAF= 0.00465%, 75/1613598 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 6.27221e-05; MAF= 0.00627%, 74/1179808 alleles, homozygotes = 0); grpmax FAF= 5.111e-05.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 7.0823e-06; MAF= 0.00071%, 2/282394 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 1.55222e-05; MAF= 0.00155%, 2/128848 alleles, homozygotes = 0).
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.0046% · 75 / 1,613,598
      0 hom · FAF 0.0051%
      European (non-Finnish)
      74 / 1,179,808
      0.0063%
      African/African American
      1 / 74,856
      0.0013%
      + 8 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish)
      gnomAD v2.1
      0.00071% · 2 / 282,394
      0 hom
      European (non-Finnish)
      2 / 128,848
      0.0016%
      + 7 not observed (African/African American, Admixed American, Ashkenazi Jewish, East Asian, European (Finnish), Remaining individuals, South Asian)
      ClinVar screenshot
      ClinVar
      This variant is absent from ClinVar.
      SpliceAI screenshot
      In silico
      SpliceAI predicts possible splice impact for this variant (max delta score = 0.89).
      Functional No data
      No calibrated functional assay or RNA evidence was identified for this variant.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Somatic evidence
      COSMIC
      This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant cancer hotspot.
      COSMIC ↗
      Sources & reference links
      7Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC